Inventor
BLUM CHARLES A
US28 patents
⚠️ This page may combine multiple inventors who share the name “BLUM CHARLES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROGEN CORP
20 patentsUS7074799B2Jul 11, 2006
Substituted quinazolin-4-ylamine analogues
NEUROGEN CORP48 citations95
US6316617B1Nov 13, 2001
Certain amido-and amino-substituted benzylamine derivatives; a new class of Neuropeptide Y1 specific ligands
NEUROGEN CORP17 citations92
US6133265AOct 17, 2000
Certain amido- and amino- substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands
NEUROGEN CORP33 citations92
US6127395AOct 3, 2000
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
NEUROGEN CORP18 citations92
US5962455AOct 5, 1999
Certain substituted benzylamine derivatives a new class of neuropeptide Y1 specific ligands
NEUROGEN CORP44 citations92
US5637724AJun 10, 1997
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
NEUROGEN CORP21 citations92
US7566712B2Jul 28, 2009
Biaryl piperazinyl-pyridine analogues
NEUROGEN CORP11 citations84
US6515133B1Feb 4, 2003
Pharmaceutical compositions containing certain diarylimidazole derivatives
NEUROGEN CORP16 citations84
US7304059B2Dec 4, 2007
Substituted quinazolin-4-ylamine analogues
NEUROGEN CORP10 citations83
US8003656B2Aug 23, 2011
2-phenoxy pyrimidinone analogues
NEUROGEN CORP10 citations82
US7432275B2Oct 7, 2008
Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
NEUROGEN CORP18 citations82
US5936095AAug 10, 1999
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
NEUROGEN CORP15 citations82
US5849927ADec 15, 1998
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
NEUROGEN CORP16 citations82
US5637725AJun 10, 1997
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
NEUROGEN CORP16 citations82
US6121260ASep 19, 2000
Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
NEUROGEN CORP13 citations74
US5985873ANov 16, 1999
Certain substituted benzylamine derivatives a new class of Neuropeptide-Y1 specific ligands
NEUROGEN CORP9 citations74
US5367077ANov 22, 1994
Certain cycloalkyl and azacycloalkyl pyrrolopyridines; a new class of gaba rain receptor ligands
NEUROGEN CORP17 citations69
US7662830B2Feb 16, 2010
Substituted biaryl piperazinyl-pyridine analogues
NEUROGEN CORP2 citations62
US7329664B2Feb 12, 2008
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
NEUROGEN CORP5 citations62
US7034034B2Apr 25, 2006
Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives
NEUROGEN CORP0 citations40
GLAXOSMITHKLINE LLC
3 patentsUS9834558B2Dec 5, 2017
Substituted bridged urea analogs as sirtuin modulators
GLAXOSMITHKLINE LLC2 citations71
US9765075B2Sep 19, 2017
Substituted bridged urea analogs as sirtuin modulators
GLAXOSMITHKLINE LLC2 citations71
US10590135B2Mar 17, 2020
Substituted bridged urea analogs as sirtuin modulators
GLAXOSMITHKLINE LLC0 citations50